XML 38 R16.htm IDEA: XBRL DOCUMENT
v3.21.1

Financial Instruments and Fair Value Measurements | 12 Months Ended
--- | ---
Apr. 02, 2021
Fair Value Disclosures [Abstract] |
Financial Instruments and Fair Value Measurements | Financial Instruments and Fair Value Measurements The following table summarizes our financial instruments measured at fair value on a recurring basis:
| April 2, 2021 |  | April 3, 2020
(In millions) | Fair Value |  | Level 1 |  | Level 2 |  | Fair Value |  | Level 1 |  | Level 2
Assets: |  |  |  |  |  |  |  |  |  |  |
Money market funds | $ | 284 |  |  | $ | 284 |  |  | $ | — |  |  | $ | 1,346 |  |  | $ | 1,346 |  |  | $ | — |
Certificates of deposit | 1 |  |  | — |  |  | 1 |  |  | 348 |  |  | — |  |  | 348 |
Corporate bonds | 17 |  |  | — |  |  | 17 |  |  | 86 |  |  | — |  |  | 86 |
Total | $ | 302 |  |  | $ | 284 |  |  | $ | 18 |  |  | $ | 1,780 |  |  | $ | 1,346 |  |  | $ | 434 |
The following table presents the contractual maturities of our investments in debt securities as of April 2, 2021:
(In millions) | Fair Value
Due in one year or less | $ | 14 |
Due after one year through five years | 4 |
Total | $ | 18 |
Actual maturities may differ from the contractual maturities because borrowers may have the right to call or prepay certain obligations. Financial instruments not recorded at fair value on a recurring basis include our non-marketable equity investments, equity method investment, and our long-term debt. Non-marketable equity investments As of April 2, 2021 and April 3, 2020, the carrying value of our non-marketable equity investments was $185 million and $187 million, respectively. Equity method investment Our investment in equity securities that was accounted for using the equity method was divested during fiscal 2020 and consisted of our equity investment in DigiCert. On October 16, 2019, Clearlake Capital Group, L.P, a private investment firm, and TA Associates, an investor of DigiCert and private equity firm, completed a joint investment in DigiCert. As a result, we sold our equity investment in DigiCert for $380 million in cash and recognized a gain on sale of $379 million in fiscal 2020. We recorded a loss from our equity interest of $31 million and $101 million during 2020 and 2019, respectively, in Other income (expense), net in our Consolidated Statements of Operations. This loss was reflected as a reduction in the carrying amount of our investment in equity interests in our Consolidated Balance Sheets. DigiCert’s results were reported on a three month lag prior to our divestiture of our investment. The following table summarizes DigiCert’s results of operations through October 16, 2019, the date of our investment sale.
(In millions) | Period from January 1, 2019 to October 16, 2019 (unaudited) |  | Year Ended December 31, 2018
Revenue | $ | 350 |  |  | $ | 313 |
Gross profit | $ | 293 |  |  | $ | 250 |
Net loss | $ | (102) |  |  | $ | (342) |
Current and long-term debt As of April 2, 2021 and April 3, 2020, the total fair value of our current and long-term fixed rate debt was $2,400 million and $3,634 million, respectively. The fair value of our variable rate debt approximated their carrying value. The fair values of all our debt obligations were based on Level 2 inputs.

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration